---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-025553"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:45:59.374636+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health reports preliminary Q1 2026 revenue of $9.6-$9.7M, up 3-4% YoY

## Summary
- Revenue expected $9.6M-$9.7M, 3-4% increase vs Q1 2025, within prior guidance.
- CEO notes several large deals slid out of Q1, impacting the lower end of guidance.
- Wound care market facing reimbursement changes for skin substitutes, causing pause.
- High interest at SAWC conference; CEO says they are leaning in, not pulling back.
- Preliminary results subject to adjustment after completion of quarter-end close.

## SEC filing metadata
- accession: 0001628280-26-025553
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828026025553/0001628280-26-025553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828026025553/snwv-20260416.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-025553
- JSON: https://secwatch.observer/filing/0001628280-26-025553.json
- Plain text: https://secwatch.observer/filing/0001628280-26-025553.txt

## Key facts
- Earnings Releases
  SANUWAVE Health, Inc. reported first quarter ended March 31, 2026 results: revenue $9.6 million to $9.7 million. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2026
  - Revenue: $9.6 million to $9.7 million
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000162828026025553/0001628280-26-025553-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.